1. Academic Validation
  2. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis

Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis

  • Cancer Res. 1999 Mar 1;59(5):999-1002.
S M Srinivasula 1 M Ahmad Y Guo Y Zhan Y Lazebnik T Fernandes-Alnemri E S Alnemri
Affiliations

Affiliation

  • 1 Center for Apoptosis Research and Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
PMID: 10070954
Abstract

Alternatively spliced isoforms of certain Apoptosis regulators, such as Bcl-x, Ced-4, and Ich-1, have been shown to play opposing roles in regulating Apoptosis. Here, we describe the identification of an endogenous alternatively spliced isoform of caspase-9, named caspase-9b, which lacks the central large subunit Caspase domain. Caspase-9b is detectable in many cell lines by PCR and at the mRNA and protein levels. Caspase-9b can interact with the Caspase recruitment domain of Apaf-1, and like the active site mutant of caspase-9, it can inhibit multiple forms of Apoptosis, including those triggered by oligomerization of death receptors. It can also block activation of caspase-9 and -3 by Apaf-1 in an in vitro cytochrome c-dependent Caspase activation assay. These results suggest that caspase-9b functions as an endogenous Apoptosis inhibitory molecule by interfering with the formation of a functional Apaf-1-caspase-9 complex.

Figures